- R&D
Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.
Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical organizations through an oversubscribed funding round. These include HanAll Biopharma,...Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech
According to the partnership, KVK Tech will formulate the oral COVID medication and also offer CMC data. KVK tech...Access to Lumykras increased in the U.K through collaboration between Amgen and NHS
The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand the distribution of Lumykras, a treatment option for lung cancer....Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics
Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for the disease known as LAMA2-deficient congenital muscular dystrophy, or LAMA2...
- Clinical
AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19
UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million. The agreement between the two...Avillion and AstraZeneca combination medicine presents positive results for people living with asthma 
The New England Journal of Medicine has published the results of Avillion and AstraZeneca’s PT027 after participation in the MANDALA Phase III...The European Commission allows Beovu to be used in the Treatment of DME
Following success in Phase III RCT KESTREL and KITE, Novartis’ Beovu will be used for diabetic macular edema The...FDA approves prostate cancer radiotherapy Pluvicto developed by Novartis
The Swiss pharmaceutical company Novartis has managed to nab FDA’s approval for Pluvicto, its second radioligand therapy. The treatment option is expected...
- Manufacturing
Spikevax COVID-19 Vaccine recalled by Moderna and Rovi
Moderna and Rovi pharmaceuticals have issued a recall of more than 750,000 doses of Spikevax, which is Moderna’s COVID-19 shot due to...Bayer to Spend $2.2 Billion in the Expansion of Manufacturing Abilities with Cell and Gene Therapies
German pharmaceutical company Bayer is looking to invest over $2 billion to enhance its production and supply chain ability to monitor gene...Cannabinoid drugs plant in the UK worth $100 million started by Jazz Pharmaceuticals
Construction begins in the United Kingdom of a manufacturing plant for the production of cannabinoid drugs. This new facility for cannabinoid drug...Pfizer’s COVID-19 pill to be manufactured by generic pharmaceutical companies
Over 90 low and middle-income countries will be able to gain access to a generic version of Pfizer’s COVID-19 treatment pill; Paxlovid,...
- Commercial
German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health
The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in the country, which is a...Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment
The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty payments. The tiered royalty payments...Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial
Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The company's oral treatment Paxlovid boost...
- Technology
Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion
United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology
An agreement has been reached between Halozyme Therapeutics and Chugai Pharmaceutical where the latter paid a $25 million payment upfront to use...Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector
Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become partners in leading digital technologies in the pharma sector across...$30 million strategic agreement reached between Sanofi and DarioHealth
France- based Sanofi and DarioHealth have signed a five-year deal amounting to $30 million. The strategic agreement has a...
- Regulatory
Several drug recalls hit the US market, including Pfizer’s Accupril
Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs include Jubilant’s Methylprednisolone , Aurobindo Pharma’s Cyanocobalamin Injection, Sun...$485M settlement for U.S. antitrust case against Sun Pharma’s Ranbaxy
Sun Pharmaceuticals agreed to settle class action lawsuits for its subsidiary Ranbaxy. The settlement amounts to $485 million and is the result...Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector
Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become partners in leading digital technologies in the pharma sector across...Holdout states reach a $6 billion settlement with Sacklers and Purdue Pharma in the opioid cris
A settlement worth $6 billion has been reached between the billionaire Sackler family and the states and victims of the U.S opioid...
- Insights
- More
- R&D
Turn Biotechnologies to move onto the next stage of cell rejuvenation program with the help of pharma organizations.
Turn Biotechnologies has been able to successfully secure fundraising from global pharmaceutical organizations through an oversubscribed funding round. These include HanAll Biopharma,...Covid-19 Oral Treatment to be developed jointly by Sen-Jam Pharmaceuticals and KVK Tech
According to the partnership, KVK Tech will formulate the oral COVID medication and also offer CMC data. KVK tech...Access to Lumykras increased in the U.K through collaboration between Amgen and NHS
The NHS has reached a landmark agreement with Amgen Pharmaceuticals to expand the distribution of Lumykras, a treatment option for lung cancer....Santhera advances gene therapy for LAMA2 MD through deal with Seal Therapeutics
Santhera Pharmaceuticals and Seal Therapeutics' partnership aims to develop gene therapy for the disease known as LAMA2-deficient congenital muscular dystrophy, or LAMA2...
- Clinical
AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19
UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement amounting to over $150 million. The agreement between the two...Avillion and AstraZeneca combination medicine presents positive results for people living with asthma 
The New England Journal of Medicine has published the results of Avillion and AstraZeneca’s PT027 after participation in the MANDALA Phase III...The European Commission allows Beovu to be used in the Treatment of DME
Following success in Phase III RCT KESTREL and KITE, Novartis’ Beovu will be used for diabetic macular edema The...FDA approves prostate cancer radiotherapy Pluvicto developed by Novartis
The Swiss pharmaceutical company Novartis has managed to nab FDA’s approval for Pluvicto, its second radioligand therapy. The treatment option is expected...
- Manufacturing
Spikevax COVID-19 Vaccine recalled by Moderna and Rovi
Moderna and Rovi pharmaceuticals have issued a recall of more than 750,000 doses of Spikevax, which is Moderna’s COVID-19 shot due to...Bayer to Spend $2.2 Billion in the Expansion of Manufacturing Abilities with Cell and Gene Therapies
German pharmaceutical company Bayer is looking to invest over $2 billion to enhance its production and supply chain ability to monitor gene...Cannabinoid drugs plant in the UK worth $100 million started by Jazz Pharmaceuticals
Construction begins in the United Kingdom of a manufacturing plant for the production of cannabinoid drugs. This new facility for cannabinoid drug...Pfizer’s COVID-19 pill to be manufactured by generic pharmaceutical companies
Over 90 low and middle-income countries will be able to gain access to a generic version of Pfizer’s COVID-19 treatment pill; Paxlovid,...
- Commercial
German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health
The projected outcome of this acquisition is a boost in operations and the initiation of collaborations in the country, which is a...Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment
The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty payments. The tiered royalty payments...Oral medication for Covid, Paxlovid boosted in Britain, courtesy of the national trial
Pfizer's COVID-19 immunization and antiviral give little indication of dialing back in the pandemic's third year. The company's oral treatment Paxlovid boost...
- Technology
Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion
United States-based Merck & Co has made an addition to its cancer-fighting drugs after entering into a contract with Chinese Pharmaceutical Company...Halozyme Therapeutics receives $25 million from Chugai Pharmaceuticals for the use of subcutaneous delivery technology
An agreement has been reached between Halozyme Therapeutics and Chugai Pharmaceutical where the latter paid a $25 million payment upfront to use...Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector
Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become partners in leading digital technologies in the pharma sector across...$30 million strategic agreement reached between Sanofi and DarioHealth
France- based Sanofi and DarioHealth have signed a five-year deal amounting to $30 million. The strategic agreement has a...
- Regulatory
Several drug recalls hit the US market, including Pfizer’s Accupril
Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs include Jubilant’s Methylprednisolone , Aurobindo Pharma’s Cyanocobalamin Injection, Sun...$485M settlement for U.S. antitrust case against Sun Pharma’s Ranbaxy
Sun Pharmaceuticals agreed to settle class action lawsuits for its subsidiary Ranbaxy. The settlement amounts to $485 million and is the result...Triastek and Siemens form a partnership to drive digital transformation in the pharmaceutical sector
Chinese pharmaceutical companies Triastek and Siemens have signed a deal to become partners in leading digital technologies in the pharma sector across...Holdout states reach a $6 billion settlement with Sacklers and Purdue Pharma in the opioid cris
A settlement worth $6 billion has been reached between the billionaire Sackler family and the states and victims of the U.S opioid...
- Insights
- More
Editor Picks
Astellas and Minovia partner to develop treatments for mitochondrial cell therapies
A global strategic partnership and license agreement has been signed between the...
Why Focus on Treating Diseases Instead of Curing Them?
It’s a tragic irony: So much money has been poured into treating...
Aerpio Pharmaceuticals and Aadi Bioscience merge with continued focus on advancing Fyarrotm
Aerpio Pharmaceuticals Inc. and Aadi Biosciences, a privately owned company, have decided to enter into a partnership.
Must Read
AstraZeneca and RQ Biotech enter into licensing agreement to develop antibodies against COVID-19
UK-based startup and British-Swedish pharma giant AstraZeneca have signed a licensing agreement...
Kelun sells cancer drug development rights to Merck in a deal worth $1.4 billion
United States-based Merck & Co has made an addition to its cancer-fighting...
German Pharmaceutical and Medical Cannabis Products Distributor to be acquired by Franchise Global Health
The projected outcome of this acquisition is a boost in operations and...
About Us
Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.
Contact us: reachout(at)lifescivoice.com